Could GLP-1 receptor agonists like semaglutide treat addiction, alzheimer disease, and other conditions
16 While GLP-1s hold promise, the evidence is not yet strong enough to call them an Alzheimers treatment or proven prevention tool
Start with the standard protocol used in my peptide cheat sheet: Dose: 250 mcg Administration: Subcutaneous injection Timing: 13 hours before bed Frequency: 5 days on, 2 days off Cycle length: 8 weeks on, followed by 8 weeks off This 250 mcg dose is the most commonly used starting point because it balances effectiveness with a very favorable safety profile
N Engl J Med 2025;393:1065-1076
Heightened PLA2 expression in these lesions triggers irregular lipid metabolic pathways, fostering excessive cellular proliferation, inflammatory cytokine release, flawed keratinization, and uncontrolled cell migration (95)